Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Stress testing for the perfect compliance storm

...as governments and regulators impose new legislation and strengthen their compliance regimes

Influence mapping to improve the efficiency and effectiveness of your messaging

As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get...

Blue Latitude Health

- PMLiVE

Amgen’s Kyprolis tops Velcade in myeloma trial

Hopes ENDEAVOR trial results will give it an edge over Takeda's brand

- PMLiVE

FDA sets August review date for Teva’s movement disorder drug

Could be first approved treatment for tardive dyskinesia

- PMLiVE

Artificial intelligence: could pharma lead the way?

Producing powerful, relevant user experiences will be one key area to target

- PMLiVE

Cuttsy+Cuttsy boosts health comms team

Charlotte Diggins joins while Jill Bradshaw and Dr Liz Walder take on new roles

- PMLiVE

Bayer: Post-truth politics severely handicaps innovation

And firm also voices its concerns over Brexit

MIT chief financial officer joins Moderna Therapeutics

Israel Ruiz to serve as audit committee chair on its board of directors

- PMLiVE

La Jolla plans filing on back of blood pressure trial data

Almost three-quarters of CRH patients met threshold for blood pressure response

- PMLiVE

AZ gets US approval for diabetes combo Qtern

Wins licensing for Onglyza/Farxiga dual-therapy after rejection by the FDA in 2015

- PMLiVE

Keeping it in the family pays dividends

How playing the long game works for family-held and foundation firms through boom and bust

- PMLiVE

Celgene’s president and COO to retire

Scott Smith set to succeed Dr Jacqualyn Fouse from 1 April

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links